Edgewise Therapeutics, Inc. (EWTX) Insider Ownership

Based on data from the past 90 days ending February 07, 2026, Edgewise Therapeutics's three largest insider shareholders are TenPercentOwner Holdings A/S Novo (6.07Mn shares), Director Advisors Llc Orbimed (443.79K shares), Director Peter A. Thompson (443.79K shares).

• A detailed ownership breakdown for Edgewise Therapeutics is not available at this time.
• At February 07, 2026, insider ownership concentration at Edgewise Therapeutics equals 11.87% of the company's equity base, encompassing roughly 11.81Mn shares from 99.52Mn total outstanding.
• Throughout the 90-day span concluding February 07, 2026, Edgewise Therapeutics's insider stake increased 0.27%, as collective insider positions growing from 11.78Mn shares to 11.81Mn shares.
• Over the past 90 days through February 07, 2026, Director Badreddin Edris demonstrated the strongest insider purchase conviction at Edgewise Therapeutics, adding 115.47K shares to their position.
• As of February 07, 2026, Director Badreddin Edris executed the most significant insider divestiture at Edgewise Therapeutics, disposing of 115.47K shares over the last 90-day period.